Literature DB >> 2483948

An endothelial cell growth factor from the mouse neuroblastoma cell line NB41.

A P Levy1, R Tamargo, H Brem, D Nathans.   

Abstract

A growth factor that stimulates the proliferation of endothelial cells from human umbilical vein but is not mitogenic for fibroblastic cells is present in medium conditioned by the mouse neuroblastoma cell line NB41. In a partially purified preparation, factor activity coeluted from a reverse-phase high-pressure liquid chromatography (HPLC) column with a reduced protein of about 24 kd. Activity recovered following electrophoresis of HPLC fractions corresponded to protein of 43-51 kd in the absence of reducing agent and to protein of 23-29 kd after reduction. Antiserum raised against a peptide corresponding to the putative N-terminal amino acid sequence of the 24-kd protein reacted with the 24-kd protein and with a protein of about 47 kd in the nonreduced preparation. After N-glycanase treatment, the immunoreactive 24-kd protein had a mobility corresponding to 19 kd. We infer that the native NB41 factor is a glycosylated dimer whose biochemical and biological properties distinguish if from other endothelial cell growth factors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2483948     DOI: 10.3109/08977198909069077

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  11 in total

1.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  The placenta growth factor gene of the mouse.

Authors:  T DiPalma; M Tucci; G Russo; D Maglione; C T Lago; A Romano; S Saccone; G Della Valle; L De Gregorio; T A Dragani; G Viglietto; M G Persico
Journal:  Mamm Genome       Date:  1996-01       Impact factor: 2.957

Review 3.  Angiogenesis and vasculogenesis in treatment of cardiovascular disease.

Authors:  A Rivard; J M Isner
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

4.  Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.

Authors:  L B Jakeman; J Winer; G L Bennett; C A Altar; N Ferrara
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 5.  The role of mitochondria in angiogenesis.

Authors:  Andrew Reichard; Kewal Asosingh
Journal:  Mol Biol Rep       Date:  2018-11-20       Impact factor: 2.316

Review 6.  Antiangiogenesis as a novel therapeutic concept in pediatric oncology.

Authors:  L Schweigerer
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

7.  VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy.

Authors:  M I Hobson; C J Green; G Terenghi
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

8.  Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability.

Authors:  K P Claffey; S C Shih; A Mullen; S Dziennis; J L Cusick; K R Abrams; S W Lee; M Detmar
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 4.138

9.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.

Authors:  S Takeshita; L P Zheng; E Brogi; M Kearney; L Q Pu; S Bunting; N Ferrara; J F Symes; J M Isner
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

Authors:  R A Berkman; M J Merrill; W C Reinhold; W T Monacci; A Saxena; W C Clark; J T Robertson; I U Ali; E H Oldfield
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.